Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Nordisk
Pharma
Novo Nordisk attracts lawmakers' ire for Levemir insulin pull
Novo Nordisk is facing lawmaker pushback over its decision to discontinue its insulin product Levemir, which was due for a steep discount in January.
Fraiser Kansteiner
Apr 18, 2024 10:40am
Eli Lilly's tirzepatide excels in phase 3 sleep apnea studies
Apr 17, 2024 11:04am
Top 20 pharma companies by 2023 revenue
Apr 15, 2024 3:00am
FTC to review Novo Holdings' Catalent buyout for 30 more days
Apr 8, 2024 11:58am
Eisai, Carvykti, Ozempic biosimilar—Fierce Pharma Asia
Apr 5, 2024 8:25am
Novo Nordisk triumphs in UK probe of 'hyperbolic' Wegovy claims
Apr 3, 2024 8:46am